3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis
Clinical trial NCT04931667 · TERMINATED
Trial details
- NCT number
- NCT04931667
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2021-12-13
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.